Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis.

IF 3.3 Q2 GASTROENTEROLOGY & HEPATOLOGY BMJ Open Gastroenterology Pub Date : 2024-11-14 DOI:10.1136/bmjgast-2024-001587
Jieqi Zheng, Zinan Fan, Chao Li, Daiyue Wang, Shenghong Zhang, Rirong Chen
{"title":"Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis.","authors":"Jieqi Zheng, Zinan Fan, Chao Li, Daiyue Wang, Shenghong Zhang, Rirong Chen","doi":"10.1136/bmjgast-2024-001587","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Acute severe ulcerative colitis (ASUC) poses challenges to patient management owing to its high surgical rate. This study aimed to identify predictors of colectomy in patients with ASUC.</p><p><strong>Design: </strong>This is a systematic review and meta-analysis.</p><p><strong>Data sources: </strong>PubMed and Web of Science were searched up to April 2024.</p><p><strong>Eligibility criteria: </strong>Studies on the predictors of colectomy in adult patients with ASUC were eligible.</p><p><strong>Data extraction and synthesis: </strong>Two reviewers independently extracted the data using a prespecified data collection sheet. A qualitative synthesis was performed in tabular form. Random-effect meta-analyses were conducted using OR and 95% CI.</p><p><strong>Results: </strong>Forty-two studies were included in the systematic review. The reported variables can be categorised into biomarkers, auxiliary examination findings, demographic and clinical characteristics, and drug factors. Through meta-analysis, albumin (OR 0.39 (95% CI 0.26 to 0.59) per 1 g/dL increment, I<sup>2</sup>=0.0%), high C reactive protein level (2.63 (1.53 to 4.52), I<sup>2</sup>=29.6%), high erythrocyte sedimentation rate level (2.92 (1.39 to 6.14), I<sup>2</sup>=0.0%), low haemoglobin level (2.08 (1.07 to 4.07), I<sup>2</sup>=56.4%), fulfilling the Oxford criteria (4.42 (2.85 to 6.84), I<sup>2</sup>=0.0%), extensive colitis (1.85 (1.24 to 2.78), I<sup>2</sup>=47.5%), previous steroids (1.75 (1.23 to 2.50), I<sup>2</sup>=17.7%) or azathioprine (2.25 (1.28 to 3.96), I<sup>2</sup>=0.0%) use, and sarcopenia (1.90 (1.04 to 3.45), I<sup>2</sup>=0.0%) were identified as valuable predictors for colectomy within 1 year. The ulcerative colitis endoscopic index of severity (OR 2.41 (95% CI 1.72 to 3.39), I<sup>2</sup>=1.5%) was the only predictor found to predict colectomy over 1 year.</p><p><strong>Conclusion: </strong>Identification of these predictors may facilitate risk stratification of patients with ASUC, drive personalised treatment and reduce the need for colectomy.</p>","PeriodicalId":9235,"journal":{"name":"BMJ Open Gastroenterology","volume":"11 1","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575343/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjgast-2024-001587","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Acute severe ulcerative colitis (ASUC) poses challenges to patient management owing to its high surgical rate. This study aimed to identify predictors of colectomy in patients with ASUC.

Design: This is a systematic review and meta-analysis.

Data sources: PubMed and Web of Science were searched up to April 2024.

Eligibility criteria: Studies on the predictors of colectomy in adult patients with ASUC were eligible.

Data extraction and synthesis: Two reviewers independently extracted the data using a prespecified data collection sheet. A qualitative synthesis was performed in tabular form. Random-effect meta-analyses were conducted using OR and 95% CI.

Results: Forty-two studies were included in the systematic review. The reported variables can be categorised into biomarkers, auxiliary examination findings, demographic and clinical characteristics, and drug factors. Through meta-analysis, albumin (OR 0.39 (95% CI 0.26 to 0.59) per 1 g/dL increment, I2=0.0%), high C reactive protein level (2.63 (1.53 to 4.52), I2=29.6%), high erythrocyte sedimentation rate level (2.92 (1.39 to 6.14), I2=0.0%), low haemoglobin level (2.08 (1.07 to 4.07), I2=56.4%), fulfilling the Oxford criteria (4.42 (2.85 to 6.84), I2=0.0%), extensive colitis (1.85 (1.24 to 2.78), I2=47.5%), previous steroids (1.75 (1.23 to 2.50), I2=17.7%) or azathioprine (2.25 (1.28 to 3.96), I2=0.0%) use, and sarcopenia (1.90 (1.04 to 3.45), I2=0.0%) were identified as valuable predictors for colectomy within 1 year. The ulcerative colitis endoscopic index of severity (OR 2.41 (95% CI 1.72 to 3.39), I2=1.5%) was the only predictor found to predict colectomy over 1 year.

Conclusion: Identification of these predictors may facilitate risk stratification of patients with ASUC, drive personalised treatment and reduce the need for colectomy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
急性重度溃疡性结肠炎患者进行结肠切除术的预测因素:系统综述和荟萃分析。
目的:急性重度溃疡性结肠炎(ASUC)手术率高,给患者管理带来挑战。本研究旨在确定ASUC患者进行结肠切除术的预测因素:这是一项系统回顾和荟萃分析:数据来源:搜索了截至 2024 年 4 月的 PubMed 和 Web of Science:数据提取和综合:两名审稿人使用预先指定的数据收集表独立提取数据。以表格形式进行定性综合。使用OR和95% CI进行随机效应荟萃分析:有 42 项研究被纳入系统综述。报告的变量可分为生物标志物、辅助检查结果、人口统计学和临床特征以及药物因素。通过荟萃分析,白蛋白(每增加 1 g/dL OR 0.39(95% CI 0.26 至 0.59),I2=0.0%)、高 C 反应蛋白水平(2.63(1.53 至 4.52),I2=29.6%)、红细胞沉降率水平高(2.92(1.39 至 6.14),I2=0.0%)、血红蛋白水平低(2.08(1.07 至 4.07),I2=56.4%)、符合牛津标准(4.42(2.85 至 6.84),I2=0.0%)、广泛结肠炎(1.85(1.24 至 2.78),I2=47.5%)、曾使用类固醇(1.75(1.23 至 2.50),I2=17.7%)或硫唑嘌呤(2.25(1.28 至 3.96),I2=0.0%)的使用以及肌肉疏松症(1.90(1.04 至 3.45),I2=0.0%)被确定为 1 年内进行结肠切除术的有价值预测因素。溃疡性结肠炎内镜严重程度指数(OR 2.41 (95% CI 1.72 to 3.39),I2=1.5%)是唯一可预测一年内是否进行结肠切除术的预测因子:这些预测因子的确定有助于对 ASUC 患者进行风险分层,推动个性化治疗并减少结肠切除术的需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMJ Open Gastroenterology
BMJ Open Gastroenterology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
5.90
自引率
3.20%
发文量
68
审稿时长
2 weeks
期刊介绍: BMJ Open Gastroenterology is an online-only, peer-reviewed, open access gastroenterology journal, dedicated to publishing high-quality medical research from all disciplines and therapeutic areas of gastroenterology. It is the open access companion journal of Gut and is co-owned by the British Society of Gastroenterology. The journal publishes all research study types, from study protocols to phase I trials to meta-analyses, including small or specialist studies. Publishing procedures are built around continuous publication, publishing research online as soon as the article is ready.
期刊最新文献
Seasonal variations in peptic ulcer disease incidence in Taiwan, a country spanning both tropical and subtropical regions: a real-world database analysis. Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis. Qualitative service evaluation of a multimodal pilot service for early detection of liver disease in high-risk groups: 'Alright My Liver?' Development of a nomogram for predicting pancreatic portal hypertension in patients with acute pancreatitis: a retrospective study. Exploring the feasibility of home-delivered capsule endoscopy with 5G support: innovations and carbon footprint insights.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1